SCHEMBL19960368

SCHEMBL19960368

Clc1cccc(Cl)c1-c1ccccc1-c1nc2ccccc2[nH]1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.76
RAB9A P51151 10/20 0.76
KDM4E B2RXH2 8/20 0.76
ALDH1A1 P00352 7/20 0.76
GPR55 Q9Y2T6 1/20 0.76
AMY1A P0DUB6 2/20 0.61
SMN1; SMN2 Q16637 5/20 0.57
NPSR1 Q6W5P4 4/20 0.57
HPGD P15428 4/20 0.57
HSD17B10 Q99714 3/20 0.57
GAA P10253 3/20 0.57
PKM P14618 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
GLA P06280 1/20 0.57
MAPT P10636 1/20 0.57
HTT P42858 1/20 0.57
TP53 P04637 2/20 0.56
ABCB11 O95342 1/20 0.56
F7 P08709 1/20 0.54
GBA1 P04062 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960367 0.89 RAB9A (0.79) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL19960358 0.87 NPC1 (0.87) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL162191 0.86 NPC1 (1.00) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL29695905 0.86 NPC1 (1.00) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL30385016 0.86 NPC1 (0.69) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL19960365 0.86 NPC1 (0.73) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL19960371 0.86 NPC1 (0.73) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL27331502 0.85 NPC1 (0.78) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL227743 0.84 NPC1 (0.78) NPC1RAB9AKDM4EALDH1A1GPR55
SCHEMBL29281313 0.83 NPC1 (0.73) NPC1RAB9AKDM4EALDH1A1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 NPC1 3974/4885RAB9A 2901/4885KDM4E 1997/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 NPC1 3974/4885RAB9A 2901/4885KDM4E 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.